nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—Naltrexone—alcohol dependence	0.141	0.228	CbGbCtD
Etravirine—CYP2C9—Disulfiram—alcohol dependence	0.135	0.218	CbGbCtD
Etravirine—CYP2C19—Citalopram—alcohol dependence	0.116	0.187	CbGbCtD
Etravirine—ABCB1—Citalopram—alcohol dependence	0.0935	0.151	CbGbCtD
Etravirine—CYP3A4—Disulfiram—alcohol dependence	0.0786	0.127	CbGbCtD
Etravirine—CYP3A4—Citalopram—alcohol dependence	0.056	0.0903	CbGbCtD
Etravirine—ABCB4—bile—alcohol dependence	0.0408	0.52	CbGeAlD
Etravirine—Sluggishness—Naltrexone—alcohol dependence	0.0119	0.0503	CcSEcCtD
Etravirine—Hepatitis C—Naltrexone—alcohol dependence	0.0106	0.0448	CcSEcCtD
Etravirine—Sluggishness—Citalopram—alcohol dependence	0.00757	0.0318	CcSEcCtD
Etravirine—ABCB4—adrenal cortex—alcohol dependence	0.00588	0.075	CbGeAlD
Etravirine—Hypersomnia—Citalopram—alcohol dependence	0.00448	0.0189	CcSEcCtD
Etravirine—ABCB4—blood—alcohol dependence	0.00425	0.0541	CbGeAlD
Etravirine—ABCB4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.004	0.0629	CbGpPWpGaD
Etravirine—Ache—Naltrexone—alcohol dependence	0.004	0.0168	CcSEcCtD
Etravirine—ABCB1—Abacavir transport and metabolism—ADH1A—alcohol dependence	0.00384	0.0603	CbGpPWpGaD
Etravirine—ABCB4—endocrine gland—alcohol dependence	0.00368	0.047	CbGeAlD
Etravirine—ABCB4—testis—alcohol dependence	0.00351	0.0448	CbGeAlD
Etravirine—Retching—Citalopram—alcohol dependence	0.00343	0.0144	CcSEcCtD
Etravirine—Night sweats—Naltrexone—alcohol dependence	0.00342	0.0144	CcSEcCtD
Etravirine—ABCB4—liver—alcohol dependence	0.00332	0.0423	CbGeAlD
Etravirine—Hepatic failure—Disulfiram—alcohol dependence	0.0032	0.0135	CcSEcCtD
Etravirine—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00306	0.0481	CbGpPWpGaD
Etravirine—Haematemesis—Acamprosate—alcohol dependence	0.00281	0.0118	CcSEcCtD
Etravirine—Neuropathy peripheral—Disulfiram—alcohol dependence	0.00217	0.00915	CcSEcCtD
Etravirine—Night sweats—Citalopram—alcohol dependence	0.00217	0.00913	CcSEcCtD
Etravirine—Disturbance in attention—Naltrexone—alcohol dependence	0.00213	0.00898	CcSEcCtD
Etravirine—Gastrooesophageal reflux disease—Naltrexone—alcohol dependence	0.00204	0.00861	CcSEcCtD
Etravirine—Hepatitis—Disulfiram—alcohol dependence	0.00199	0.00838	CcSEcCtD
Etravirine—Hypoaesthesia—Disulfiram—alcohol dependence	0.00198	0.00834	CcSEcCtD
Etravirine—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00196	0.0308	CbGpPWpGaD
Etravirine—Hypercholesterolaemia—Naltrexone—alcohol dependence	0.00195	0.00822	CcSEcCtD
Etravirine—Abnormal dreams—Acamprosate—alcohol dependence	0.00193	0.00812	CcSEcCtD
Etravirine—Abnormal dreams—Naltrexone—alcohol dependence	0.00183	0.00768	CcSEcCtD
Etravirine—Breast enlargement—Citalopram—alcohol dependence	0.0018	0.0076	CcSEcCtD
Etravirine—Nightmare—Naltrexone—alcohol dependence	0.00178	0.00751	CcSEcCtD
Etravirine—Haemoglobin decreased—Citalopram—alcohol dependence	0.0017	0.00716	CcSEcCtD
Etravirine—Haematemesis—Citalopram—alcohol dependence	0.00168	0.00709	CcSEcCtD
Etravirine—Diabetes mellitus—Acamprosate—alcohol dependence	0.00163	0.00686	CcSEcCtD
Etravirine—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00162	0.0255	CbGpPWpGaD
Etravirine—Hyperlipidaemia—Citalopram—alcohol dependence	0.00162	0.00684	CcSEcCtD
Etravirine—Sleep disorder—Naltrexone—alcohol dependence	0.00155	0.00652	CcSEcCtD
Etravirine—Renal failure acute—Acamprosate—alcohol dependence	0.00153	0.00646	CcSEcCtD
Etravirine—Amnesia—Acamprosate—alcohol dependence	0.00151	0.00635	CcSEcCtD
Etravirine—Disorientation—Naltrexone—alcohol dependence	0.0015	0.00631	CcSEcCtD
Etravirine—Dermatitis bullous—Acamprosate—alcohol dependence	0.00148	0.00624	CcSEcCtD
Etravirine—Atrial fibrillation—Naltrexone—alcohol dependence	0.00141	0.00596	CcSEcCtD
Etravirine—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00138	0.0217	CbGpPWpGaD
Etravirine—Disturbance in attention—Citalopram—alcohol dependence	0.00135	0.00569	CcSEcCtD
Etravirine—Rhabdomyolysis—Citalopram—alcohol dependence	0.00132	0.00557	CcSEcCtD
Etravirine—CYP2C19—CYP2E1 reactions—CYP2E1—alcohol dependence	0.0013	0.0205	CbGpPWpGaD
Etravirine—Dry skin—Acamprosate—alcohol dependence	0.0013	0.00547	CcSEcCtD
Etravirine—Gastrooesophageal reflux disease—Citalopram—alcohol dependence	0.0013	0.00545	CcSEcCtD
Etravirine—Breast disorder—Acamprosate—alcohol dependence	0.00128	0.00539	CcSEcCtD
Etravirine—Paraesthesia—Disulfiram—alcohol dependence	0.00127	0.00534	CcSEcCtD
Etravirine—Somnolence—Disulfiram—alcohol dependence	0.00126	0.00529	CcSEcCtD
Etravirine—Gastritis—Acamprosate—alcohol dependence	0.00125	0.00528	CcSEcCtD
Etravirine—Hypercholesterolaemia—Citalopram—alcohol dependence	0.00124	0.00521	CcSEcCtD
Etravirine—Abdominal distension—Acamprosate—alcohol dependence	0.00123	0.00519	CcSEcCtD
Etravirine—Fatigue—Disulfiram—alcohol dependence	0.00122	0.00513	CcSEcCtD
Etravirine—Eosinophilia—Acamprosate—alcohol dependence	0.00121	0.00511	CcSEcCtD
Etravirine—Pain—Disulfiram—alcohol dependence	0.00121	0.00509	CcSEcCtD
Etravirine—Pancreatitis—Acamprosate—alcohol dependence	0.0012	0.00506	CcSEcCtD
Etravirine—Angina pectoris—Acamprosate—alcohol dependence	0.00119	0.00502	CcSEcCtD
Etravirine—CYP2C9—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00119	0.0187	CbGpPWpGaD
Etravirine—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00117	0.0185	CbGpPWpGaD
Etravirine—Abnormal dreams—Citalopram—alcohol dependence	0.00116	0.00487	CcSEcCtD
Etravirine—Nightmare—Citalopram—alcohol dependence	0.00113	0.00476	CcSEcCtD
Etravirine—Angina pectoris—Naltrexone—alcohol dependence	0.00113	0.00475	CcSEcCtD
Etravirine—Hyperglycaemia—Acamprosate—alcohol dependence	0.0011	0.00465	CcSEcCtD
Etravirine—ABCB1—Allograft Rejection—PECR—alcohol dependence	0.00109	0.0171	CbGpPWpGaD
Etravirine—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00108	0.00453	CcSEcCtD
Etravirine—Myocardial infarction—Acamprosate—alcohol dependence	0.00107	0.00451	CcSEcCtD
Etravirine—Stomatitis—Acamprosate—alcohol dependence	0.00106	0.00448	CcSEcCtD
Etravirine—CYP2C19—digestive system—alcohol dependence	0.00105	0.0134	CbGeAlD
Etravirine—Gynaecomastia—Citalopram—alcohol dependence	0.00105	0.00441	CcSEcCtD
Etravirine—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00103	0.0162	CbGpPWpGaD
Etravirine—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00103	0.0162	CbGpPWpGaD
Etravirine—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00102	0.00429	CcSEcCtD
Etravirine—Asthenia—Disulfiram—alcohol dependence	0.00101	0.00427	CcSEcCtD
Etravirine—Myocardial infarction—Naltrexone—alcohol dependence	0.00101	0.00426	CcSEcCtD
Etravirine—Conjunctivitis—Naltrexone—alcohol dependence	0.001	0.00423	CcSEcCtD
Etravirine—CYP2C19—blood—alcohol dependence	0.001	0.0128	CbGeAlD
Etravirine—CYP2C9—cardiovascular system—alcohol dependence	0.000982	0.0125	CbGeAlD
Etravirine—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.000981	0.0154	CbGpPWpGaD
Etravirine—Sleep disorder—Citalopram—alcohol dependence	0.000981	0.00413	CcSEcCtD
Etravirine—Hepatitis—Acamprosate—alcohol dependence	0.00098	0.00413	CcSEcCtD
Etravirine—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000977	0.00411	CcSEcCtD
Etravirine—Diabetes mellitus—Citalopram—alcohol dependence	0.000977	0.00411	CcSEcCtD
Etravirine—Hypoaesthesia—Acamprosate—alcohol dependence	0.000975	0.00411	CcSEcCtD
Etravirine—Disorientation—Citalopram—alcohol dependence	0.00095	0.004	CcSEcCtD
Etravirine—Hepatic failure—Citalopram—alcohol dependence	0.000945	0.00398	CcSEcCtD
Etravirine—Haemolytic anaemia—Citalopram—alcohol dependence	0.000941	0.00396	CcSEcCtD
Etravirine—Dizziness—Disulfiram—alcohol dependence	0.000935	0.00394	CcSEcCtD
Etravirine—Hepatitis—Naltrexone—alcohol dependence	0.000928	0.0039	CcSEcCtD
Etravirine—Renal failure acute—Citalopram—alcohol dependence	0.00092	0.00387	CcSEcCtD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000918	0.0144	CbGpPWpGaD
Etravirine—Connective tissue disorder—Naltrexone—alcohol dependence	0.000911	0.00384	CcSEcCtD
Etravirine—Amnesia—Citalopram—alcohol dependence	0.000904	0.00381	CcSEcCtD
Etravirine—Atrial fibrillation—Citalopram—alcohol dependence	0.000896	0.00377	CcSEcCtD
Etravirine—Rash—Disulfiram—alcohol dependence	0.000891	0.00375	CcSEcCtD
Etravirine—Dermatitis bullous—Citalopram—alcohol dependence	0.000889	0.00374	CcSEcCtD
Etravirine—Headache—Disulfiram—alcohol dependence	0.000886	0.00373	CcSEcCtD
Etravirine—Immune system disorder—Acamprosate—alcohol dependence	0.000885	0.00373	CcSEcCtD
Etravirine—CYP2C19—endocrine gland—alcohol dependence	0.000869	0.0111	CbGeAlD
Etravirine—Eye disorder—Naltrexone—alcohol dependence	0.000867	0.00365	CcSEcCtD
Etravirine—Cardiac disorder—Naltrexone—alcohol dependence	0.000861	0.00362	CcSEcCtD
Etravirine—Mental disorder—Acamprosate—alcohol dependence	0.000859	0.00362	CcSEcCtD
Etravirine—Malnutrition—Acamprosate—alcohol dependence	0.000853	0.00359	CcSEcCtD
Etravirine—Angiopathy—Naltrexone—alcohol dependence	0.000842	0.00354	CcSEcCtD
Etravirine—Flatulence—Acamprosate—alcohol dependence	0.000841	0.00354	CcSEcCtD
Etravirine—Immune system disorder—Naltrexone—alcohol dependence	0.000838	0.00353	CcSEcCtD
Etravirine—Tension—Acamprosate—alcohol dependence	0.000837	0.00353	CcSEcCtD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000837	0.0132	CbGpPWpGaD
Etravirine—Mediastinal disorder—Naltrexone—alcohol dependence	0.000836	0.00352	CcSEcCtD
Etravirine—Nervousness—Acamprosate—alcohol dependence	0.000829	0.00349	CcSEcCtD
Etravirine—CYP2C9—digestive system—alcohol dependence	0.000815	0.0104	CbGeAlD
Etravirine—Mental disorder—Naltrexone—alcohol dependence	0.000813	0.00342	CcSEcCtD
Etravirine—Malnutrition—Naltrexone—alcohol dependence	0.000807	0.0034	CcSEcCtD
Etravirine—CYP2C19—Xenobiotics—CYP2E1—alcohol dependence	0.000807	0.0127	CbGpPWpGaD
Etravirine—Tremor—Acamprosate—alcohol dependence	0.0008	0.00337	CcSEcCtD
Etravirine—Flatulence—Naltrexone—alcohol dependence	0.000796	0.00335	CcSEcCtD
Etravirine—Tension—Naltrexone—alcohol dependence	0.000792	0.00334	CcSEcCtD
Etravirine—Ill-defined disorder—Acamprosate—alcohol dependence	0.000792	0.00333	CcSEcCtD
Etravirine—Anaemia—Acamprosate—alcohol dependence	0.000789	0.00332	CcSEcCtD
Etravirine—Nervousness—Naltrexone—alcohol dependence	0.000784	0.0033	CcSEcCtD
Etravirine—CYP2C19—liver—alcohol dependence	0.000784	0.00999	CbGeAlD
Etravirine—Angioedema—Acamprosate—alcohol dependence	0.00078	0.00328	CcSEcCtD
Etravirine—Dry skin—Citalopram—alcohol dependence	0.000779	0.00328	CcSEcCtD
Etravirine—CYP2C9—blood—alcohol dependence	0.000777	0.0099	CbGeAlD
Etravirine—CYP2C19—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000776	0.0122	CbGpPWpGaD
Etravirine—Malaise—Acamprosate—alcohol dependence	0.00077	0.00324	CcSEcCtD
Etravirine—Breast disorder—Citalopram—alcohol dependence	0.000768	0.00323	CcSEcCtD
Etravirine—Vertigo—Acamprosate—alcohol dependence	0.000767	0.00323	CcSEcCtD
Etravirine—Syncope—Acamprosate—alcohol dependence	0.000765	0.00322	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.000765	0.00322	CcSEcCtD
Etravirine—Vision blurred—Naltrexone—alcohol dependence	0.000761	0.0032	CcSEcCtD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000761	0.012	CbGpPWpGaD
Etravirine—Tremor—Naltrexone—alcohol dependence	0.000756	0.00318	CcSEcCtD
Etravirine—Gastritis—Citalopram—alcohol dependence	0.000752	0.00317	CcSEcCtD
Etravirine—Loss of consciousness—Acamprosate—alcohol dependence	0.00075	0.00316	CcSEcCtD
Etravirine—Ill-defined disorder—Naltrexone—alcohol dependence	0.000749	0.00315	CcSEcCtD
Etravirine—Convulsion—Acamprosate—alcohol dependence	0.000739	0.00311	CcSEcCtD
Etravirine—Abdominal distension—Citalopram—alcohol dependence	0.000739	0.00311	CcSEcCtD
Etravirine—Angioedema—Naltrexone—alcohol dependence	0.000738	0.00311	CcSEcCtD
Etravirine—Hypertension—Acamprosate—alcohol dependence	0.000737	0.0031	CcSEcCtD
Etravirine—CYP2C9—Xenobiotics—CYP2E1—alcohol dependence	0.000736	0.0116	CbGpPWpGaD
Etravirine—Malaise—Naltrexone—alcohol dependence	0.000728	0.00307	CcSEcCtD
Etravirine—Eosinophilia—Citalopram—alcohol dependence	0.000727	0.00306	CcSEcCtD
Etravirine—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000726	0.0114	CbGpPWpGaD
Etravirine—Syncope—Naltrexone—alcohol dependence	0.000724	0.00305	CcSEcCtD
Etravirine—Anxiety—Acamprosate—alcohol dependence	0.000724	0.00305	CcSEcCtD
Etravirine—Bronchospasm—Citalopram—alcohol dependence	0.000722	0.00304	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000722	0.00304	CcSEcCtD
Etravirine—Pancreatitis—Citalopram—alcohol dependence	0.00072	0.00303	CcSEcCtD
Etravirine—Discomfort—Acamprosate—alcohol dependence	0.000718	0.00302	CcSEcCtD
Etravirine—Angina pectoris—Citalopram—alcohol dependence	0.000715	0.00301	CcSEcCtD
Etravirine—Dry mouth—Acamprosate—alcohol dependence	0.000711	0.00299	CcSEcCtD
Etravirine—Loss of consciousness—Naltrexone—alcohol dependence	0.00071	0.00299	CcSEcCtD
Etravirine—CYP2C9—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000708	0.0111	CbGpPWpGaD
Etravirine—Confusional state—Acamprosate—alcohol dependence	0.000702	0.00296	CcSEcCtD
Etravirine—Convulsion—Naltrexone—alcohol dependence	0.0007	0.00295	CcSEcCtD
Etravirine—Hypertension—Naltrexone—alcohol dependence	0.000697	0.00293	CcSEcCtD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000694	0.0109	CbGpPWpGaD
Etravirine—Infection—Acamprosate—alcohol dependence	0.000692	0.00291	CcSEcCtD
Etravirine—Shock—Acamprosate—alcohol dependence	0.000685	0.00288	CcSEcCtD
Etravirine—Anxiety—Naltrexone—alcohol dependence	0.000685	0.00288	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000683	0.00287	CcSEcCtD
Etravirine—Thrombocytopenia—Acamprosate—alcohol dependence	0.000682	0.00287	CcSEcCtD
Etravirine—Discomfort—Naltrexone—alcohol dependence	0.000679	0.00286	CcSEcCtD
Etravirine—Skin disorder—Acamprosate—alcohol dependence	0.000677	0.00285	CcSEcCtD
Etravirine—CYP2C9—endocrine gland—alcohol dependence	0.000674	0.00859	CbGeAlD
Etravirine—Hyperhidrosis—Acamprosate—alcohol dependence	0.000673	0.00283	CcSEcCtD
Etravirine—Dry mouth—Naltrexone—alcohol dependence	0.000672	0.00283	CcSEcCtD
Etravirine—Confusional state—Naltrexone—alcohol dependence	0.000664	0.0028	CcSEcCtD
Etravirine—Anorexia—Acamprosate—alcohol dependence	0.000664	0.00279	CcSEcCtD
Etravirine—Hyperglycaemia—Citalopram—alcohol dependence	0.000662	0.00279	CcSEcCtD
Etravirine—Infection—Naltrexone—alcohol dependence	0.000655	0.00276	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000649	0.00273	CcSEcCtD
Etravirine—Shock—Naltrexone—alcohol dependence	0.000648	0.00273	CcSEcCtD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000647	0.0102	CbGpPWpGaD
Etravirine—Nervous system disorder—Naltrexone—alcohol dependence	0.000646	0.00272	CcSEcCtD
Etravirine—Acute coronary syndrome—Citalopram—alcohol dependence	0.000645	0.00272	CcSEcCtD
Etravirine—Neuropathy peripheral—Citalopram—alcohol dependence	0.000642	0.0027	CcSEcCtD
Etravirine—Myocardial infarction—Citalopram—alcohol dependence	0.000642	0.0027	CcSEcCtD
Etravirine—Skin disorder—Naltrexone—alcohol dependence	0.00064	0.00269	CcSEcCtD
Etravirine—Stomatitis—Citalopram—alcohol dependence	0.000638	0.00269	CcSEcCtD
Etravirine—Hyperhidrosis—Naltrexone—alcohol dependence	0.000637	0.00268	CcSEcCtD
Etravirine—Conjunctivitis—Citalopram—alcohol dependence	0.000636	0.00268	CcSEcCtD
Etravirine—ABCB4—Metabolism—ADH6—alcohol dependence	0.000633	0.00994	CbGpPWpGaD
Etravirine—Insomnia—Acamprosate—alcohol dependence	0.00063	0.00265	CcSEcCtD
Etravirine—Anorexia—Naltrexone—alcohol dependence	0.000628	0.00264	CcSEcCtD
Etravirine—ABCB1—forebrain—alcohol dependence	0.000627	0.00799	CbGeAlD
Etravirine—Paraesthesia—Acamprosate—alcohol dependence	0.000625	0.00263	CcSEcCtD
Etravirine—CYP3A4—digestive system—alcohol dependence	0.000622	0.00793	CbGeAlD
Etravirine—Somnolence—Acamprosate—alcohol dependence	0.000619	0.00261	CcSEcCtD
Etravirine—Hepatobiliary disease—Citalopram—alcohol dependence	0.000619	0.00261	CcSEcCtD
Etravirine—CYP2C9—liver—alcohol dependence	0.000608	0.00774	CbGeAlD
Etravirine—Decreased appetite—Acamprosate—alcohol dependence	0.000605	0.00255	CcSEcCtD
Etravirine—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000601	0.00253	CcSEcCtD
Etravirine—Insomnia—Naltrexone—alcohol dependence	0.000596	0.00251	CcSEcCtD
Etravirine—Constipation—Acamprosate—alcohol dependence	0.000596	0.00251	CcSEcCtD
Etravirine—Pain—Acamprosate—alcohol dependence	0.000596	0.00251	CcSEcCtD
Etravirine—CYP3A4—blood—alcohol dependence	0.000592	0.00755	CbGeAlD
Etravirine—Paraesthesia—Naltrexone—alcohol dependence	0.000592	0.00249	CcSEcCtD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00059	0.00927	CbGpPWpGaD
Etravirine—Hepatitis—Citalopram—alcohol dependence	0.000588	0.00247	CcSEcCtD
Etravirine—Somnolence—Naltrexone—alcohol dependence	0.000586	0.00247	CcSEcCtD
Etravirine—Hypoaesthesia—Citalopram—alcohol dependence	0.000585	0.00246	CcSEcCtD
Etravirine—ABCB1—adrenal cortex—alcohol dependence	0.000581	0.00741	CbGeAlD
Etravirine—Urinary tract disorder—Citalopram—alcohol dependence	0.00058	0.00244	CcSEcCtD
Etravirine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00058	0.00912	CbGpPWpGaD
Etravirine—Connective tissue disorder—Citalopram—alcohol dependence	0.000578	0.00243	CcSEcCtD
Etravirine—Urethral disorder—Citalopram—alcohol dependence	0.000576	0.00243	CcSEcCtD
Etravirine—Feeling abnormal—Acamprosate—alcohol dependence	0.000574	0.00242	CcSEcCtD
Etravirine—Decreased appetite—Naltrexone—alcohol dependence	0.000573	0.00241	CcSEcCtD
Etravirine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00057	0.0024	CcSEcCtD
Etravirine—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000569	0.0024	CcSEcCtD
Etravirine—Fatigue—Naltrexone—alcohol dependence	0.000568	0.00239	CcSEcCtD
Etravirine—Pain—Naltrexone—alcohol dependence	0.000564	0.00237	CcSEcCtD
Etravirine—Constipation—Naltrexone—alcohol dependence	0.000564	0.00237	CcSEcCtD
Etravirine—ABCB4—PPARA activates gene expression—EP300—alcohol dependence	0.000556	0.00874	CbGpPWpGaD
Etravirine—Erythema multiforme—Citalopram—alcohol dependence	0.000556	0.00234	CcSEcCtD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000552	0.00868	CbGpPWpGaD
Etravirine—Body temperature increased—Acamprosate—alcohol dependence	0.000551	0.00232	CcSEcCtD
Etravirine—Abdominal pain—Acamprosate—alcohol dependence	0.000551	0.00232	CcSEcCtD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00055	0.00864	CbGpPWpGaD
Etravirine—Eye disorder—Citalopram—alcohol dependence	0.000549	0.00231	CcSEcCtD
Etravirine—Cardiac disorder—Citalopram—alcohol dependence	0.000545	0.0023	CcSEcCtD
Etravirine—ABCB4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—alcohol dependence	0.000544	0.00855	CbGpPWpGaD
Etravirine—Feeling abnormal—Naltrexone—alcohol dependence	0.000543	0.00229	CcSEcCtD
Etravirine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000539	0.00227	CcSEcCtD
Etravirine—Angiopathy—Citalopram—alcohol dependence	0.000533	0.00224	CcSEcCtD
Etravirine—Immune system disorder—Citalopram—alcohol dependence	0.000531	0.00223	CcSEcCtD
Etravirine—ABCB1—cardiovascular system—alcohol dependence	0.00053	0.00676	CbGeAlD
Etravirine—Mediastinal disorder—Citalopram—alcohol dependence	0.00053	0.00223	CcSEcCtD
Etravirine—ABCB4—Metabolism—ADH1A—alcohol dependence	0.000524	0.00824	CbGpPWpGaD
Etravirine—Body temperature increased—Naltrexone—alcohol dependence	0.000521	0.00219	CcSEcCtD
Etravirine—Abdominal pain—Naltrexone—alcohol dependence	0.000521	0.00219	CcSEcCtD
Etravirine—ABCB1—pancreas—alcohol dependence	0.000515	0.00657	CbGeAlD
Etravirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000515	0.0081	CbGpPWpGaD
Etravirine—Mental disorder—Citalopram—alcohol dependence	0.000515	0.00217	CcSEcCtD
Etravirine—CYP3A4—endocrine gland—alcohol dependence	0.000514	0.00655	CbGeAlD
Etravirine—Hypersensitivity—Acamprosate—alcohol dependence	0.000513	0.00216	CcSEcCtD
Etravirine—Malnutrition—Citalopram—alcohol dependence	0.000512	0.00215	CcSEcCtD
Etravirine—Flatulence—Citalopram—alcohol dependence	0.000504	0.00212	CcSEcCtD
Etravirine—Tension—Citalopram—alcohol dependence	0.000502	0.00211	CcSEcCtD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000501	0.00788	CbGpPWpGaD
Etravirine—Asthenia—Acamprosate—alcohol dependence	0.0005	0.0021	CcSEcCtD
Etravirine—Nervousness—Citalopram—alcohol dependence	0.000497	0.00209	CcSEcCtD
Etravirine—CYP2C19—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000493	0.00775	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—ADH6—alcohol dependence	0.000488	0.00766	CbGpPWpGaD
Etravirine—Hypersensitivity—Naltrexone—alcohol dependence	0.000485	0.00204	CcSEcCtD
Etravirine—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000485	0.00762	CbGpPWpGaD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000482	0.00758	CbGpPWpGaD
Etravirine—Vision blurred—Citalopram—alcohol dependence	0.000482	0.00203	CcSEcCtD
Etravirine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000481	0.00756	CbGpPWpGaD
Etravirine—ABCB1—gonad—alcohol dependence	0.000481	0.00613	CbGeAlD
Etravirine—CYP3A4—nervous system—alcohol dependence	0.000481	0.00613	CbGeAlD
Etravirine—Tremor—Citalopram—alcohol dependence	0.000479	0.00202	CcSEcCtD
Etravirine—Diarrhoea—Acamprosate—alcohol dependence	0.000477	0.00201	CcSEcCtD
Etravirine—Ill-defined disorder—Citalopram—alcohol dependence	0.000475	0.002	CcSEcCtD
Etravirine—Anaemia—Citalopram—alcohol dependence	0.000473	0.00199	CcSEcCtD
Etravirine—Asthenia—Naltrexone—alcohol dependence	0.000473	0.00199	CcSEcCtD
Etravirine—Angioedema—Citalopram—alcohol dependence	0.000467	0.00197	CcSEcCtD
Etravirine—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000467	0.00733	CbGpPWpGaD
Etravirine—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000464	0.00729	CbGpPWpGaD
Etravirine—CYP3A4—liver—alcohol dependence	0.000463	0.00591	CbGeAlD
Etravirine—CYP3A4—central nervous system—alcohol dependence	0.000463	0.0059	CbGeAlD
Etravirine—Malaise—Citalopram—alcohol dependence	0.000461	0.00194	CcSEcCtD
Etravirine—Dizziness—Acamprosate—alcohol dependence	0.000461	0.00194	CcSEcCtD
Etravirine—Vertigo—Citalopram—alcohol dependence	0.00046	0.00193	CcSEcCtD
Etravirine—Syncope—Citalopram—alcohol dependence	0.000459	0.00193	CcSEcCtD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000457	0.00719	CbGpPWpGaD
Etravirine—Diarrhoea—Naltrexone—alcohol dependence	0.000451	0.0019	CcSEcCtD
Etravirine—Loss of consciousness—Citalopram—alcohol dependence	0.00045	0.00189	CcSEcCtD
Etravirine—ABCB4—Metabolism—ADH4—alcohol dependence	0.000446	0.007	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.000445	0.00699	CbGpPWpGaD
Etravirine—Convulsion—Citalopram—alcohol dependence	0.000443	0.00187	CcSEcCtD
Etravirine—Vomiting—Acamprosate—alcohol dependence	0.000443	0.00186	CcSEcCtD
Etravirine—Hypertension—Citalopram—alcohol dependence	0.000442	0.00186	CcSEcCtD
Etravirine—ABCB1—digestive system—alcohol dependence	0.00044	0.00561	CbGeAlD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00044	0.00691	CbGpPWpGaD
Etravirine—Rash—Acamprosate—alcohol dependence	0.000439	0.00185	CcSEcCtD
Etravirine—Dermatitis—Acamprosate—alcohol dependence	0.000439	0.00185	CcSEcCtD
Etravirine—Headache—Acamprosate—alcohol dependence	0.000436	0.00184	CcSEcCtD
Etravirine—Dizziness—Naltrexone—alcohol dependence	0.000436	0.00183	CcSEcCtD
Etravirine—Anxiety—Citalopram—alcohol dependence	0.000434	0.00183	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000433	0.00182	CcSEcCtD
Etravirine—Discomfort—Citalopram—alcohol dependence	0.00043	0.00181	CcSEcCtD
Etravirine—Dry mouth—Citalopram—alcohol dependence	0.000426	0.00179	CcSEcCtD
Etravirine—Confusional state—Citalopram—alcohol dependence	0.000421	0.00177	CcSEcCtD
Etravirine—ABCB1—blood—alcohol dependence	0.000419	0.00535	CbGeAlD
Etravirine—Vomiting—Naltrexone—alcohol dependence	0.000419	0.00176	CcSEcCtD
Etravirine—Rash—Naltrexone—alcohol dependence	0.000415	0.00175	CcSEcCtD
Etravirine—Dermatitis—Naltrexone—alcohol dependence	0.000415	0.00175	CcSEcCtD
Etravirine—Infection—Citalopram—alcohol dependence	0.000415	0.00175	CcSEcCtD
Etravirine—ABCB1—midbrain—alcohol dependence	0.000414	0.00528	CbGeAlD
Etravirine—Nausea—Acamprosate—alcohol dependence	0.000414	0.00174	CcSEcCtD
Etravirine—Headache—Naltrexone—alcohol dependence	0.000413	0.00174	CcSEcCtD
Etravirine—Shock—Citalopram—alcohol dependence	0.000411	0.00173	CcSEcCtD
Etravirine—Nervous system disorder—Citalopram—alcohol dependence	0.000409	0.00172	CcSEcCtD
Etravirine—Thrombocytopenia—Citalopram—alcohol dependence	0.000409	0.00172	CcSEcCtD
Etravirine—Skin disorder—Citalopram—alcohol dependence	0.000406	0.00171	CcSEcCtD
Etravirine—CYP2C19—Biological oxidations—ADH1A—alcohol dependence	0.000404	0.00635	CbGpPWpGaD
Etravirine—Hyperhidrosis—Citalopram—alcohol dependence	0.000404	0.0017	CcSEcCtD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.0004	0.00628	CbGpPWpGaD
Etravirine—Anorexia—Citalopram—alcohol dependence	0.000398	0.00168	CcSEcCtD
Etravirine—Nausea—Naltrexone—alcohol dependence	0.000391	0.00165	CcSEcCtD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000389	0.00611	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000386	0.00606	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ADH7—alcohol dependence	0.000379	0.00596	CbGpPWpGaD
Etravirine—Insomnia—Citalopram—alcohol dependence	0.000378	0.00159	CcSEcCtD
Etravirine—ABCB4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—alcohol dependence	0.000375	0.00589	CbGpPWpGaD
Etravirine—Paraesthesia—Citalopram—alcohol dependence	0.000375	0.00158	CcSEcCtD
Etravirine—Somnolence—Citalopram—alcohol dependence	0.000371	0.00156	CcSEcCtD
Etravirine—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000368	0.00579	CbGpPWpGaD
Etravirine—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000367	0.00576	CbGpPWpGaD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000364	0.00573	CbGpPWpGaD
Etravirine—ABCB1—endocrine gland—alcohol dependence	0.000364	0.00464	CbGeAlD
Etravirine—ABCB4—Metabolism—GGT2—alcohol dependence	0.000363	0.00571	CbGpPWpGaD
Etravirine—Decreased appetite—Citalopram—alcohol dependence	0.000363	0.00153	CcSEcCtD
Etravirine—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00036	0.00152	CcSEcCtD
Etravirine—Fatigue—Citalopram—alcohol dependence	0.00036	0.00152	CcSEcCtD
Etravirine—Pain—Citalopram—alcohol dependence	0.000357	0.0015	CcSEcCtD
Etravirine—Constipation—Citalopram—alcohol dependence	0.000357	0.0015	CcSEcCtD
Etravirine—CYP2C19—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000356	0.00559	CbGpPWpGaD
Etravirine—ABCB1—testis—alcohol dependence	0.000347	0.00442	CbGeAlD
Etravirine—Feeling abnormal—Citalopram—alcohol dependence	0.000344	0.00145	CcSEcCtD
Etravirine—CYP2C19—Biological oxidations—ADH4—alcohol dependence	0.000344	0.0054	CbGpPWpGaD
Etravirine—Gastrointestinal pain—Citalopram—alcohol dependence	0.000341	0.00144	CcSEcCtD
Etravirine—ABCB1—nervous system—alcohol dependence	0.00034	0.00434	CbGeAlD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00034	0.00534	CbGpPWpGaD
Etravirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000335	0.00527	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ADH1B—alcohol dependence	0.000332	0.00522	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000331	0.0052	CbGpPWpGaD
Etravirine—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000331	0.0052	CbGpPWpGaD
Etravirine—Body temperature increased—Citalopram—alcohol dependence	0.00033	0.00139	CcSEcCtD
Etravirine—Abdominal pain—Citalopram—alcohol dependence	0.00033	0.00139	CcSEcCtD
Etravirine—ABCB1—liver—alcohol dependence	0.000328	0.00418	CbGeAlD
Etravirine—ABCB1—central nervous system—alcohol dependence	0.000328	0.00418	CbGeAlD
Etravirine—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000325	0.0051	CbGpPWpGaD
Etravirine—ABCB1—cerebellum—alcohol dependence	0.00032	0.00408	CbGeAlD
Etravirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000317	0.00499	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000313	0.00492	CbGpPWpGaD
Etravirine—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000312	0.0049	CbGpPWpGaD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00031	0.00487	CbGpPWpGaD
Etravirine—Hypersensitivity—Citalopram—alcohol dependence	0.000308	0.0013	CcSEcCtD
Etravirine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000306	0.0048	CbGpPWpGaD
Etravirine—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000302	0.00474	CbGpPWpGaD
Etravirine—Asthenia—Citalopram—alcohol dependence	0.0003	0.00126	CcSEcCtD
Etravirine—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000293	0.00461	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—ADH7—alcohol dependence	0.000292	0.00459	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00029	0.00456	CbGpPWpGaD
Etravirine—Diarrhoea—Citalopram—alcohol dependence	0.000286	0.0012	CcSEcCtD
Etravirine—CYP2C19—Biological oxidations—GGT2—alcohol dependence	0.00028	0.0044	CbGpPWpGaD
Etravirine—Dizziness—Citalopram—alcohol dependence	0.000276	0.00116	CcSEcCtD
Etravirine—ABCB4—Metabolism—MAOB—alcohol dependence	0.000275	0.00433	CbGpPWpGaD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000272	0.00427	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000266	0.00419	CbGpPWpGaD
Etravirine—Vomiting—Citalopram—alcohol dependence	0.000265	0.00112	CcSEcCtD
Etravirine—Rash—Citalopram—alcohol dependence	0.000263	0.00111	CcSEcCtD
Etravirine—Dermatitis—Citalopram—alcohol dependence	0.000263	0.00111	CcSEcCtD
Etravirine—Headache—Citalopram—alcohol dependence	0.000262	0.0011	CcSEcCtD
Etravirine—ABCB1—brain—alcohol dependence	0.00026	0.00332	CbGeAlD
Etravirine—CYP2C19—Biological oxidations—ADH1B—alcohol dependence	0.000256	0.00403	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000255	0.00401	CbGpPWpGaD
Etravirine—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000249	0.00392	CbGpPWpGaD
Etravirine—Nausea—Citalopram—alcohol dependence	0.000248	0.00104	CcSEcCtD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000248	0.00389	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000243	0.00382	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.00024	0.00378	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ALDH2—alcohol dependence	0.000234	0.00368	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000234	0.00367	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000225	0.00354	CbGpPWpGaD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000223	0.00351	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—MAOB—alcohol dependence	0.000212	0.00334	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000207	0.00325	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000204	0.00321	CbGpPWpGaD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000204	0.0032	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000201	0.00317	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GOT2—alcohol dependence	0.000199	0.00313	CbGpPWpGaD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000199	0.00312	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000194	0.00304	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CYP2E1—alcohol dependence	0.000187	0.00294	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—ALDH2—alcohol dependence	0.00018	0.00284	CbGpPWpGaD
Etravirine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000179	0.00282	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000176	0.00276	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GOT1—alcohol dependence	0.000172	0.0027	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GGT1—alcohol dependence	0.000172	0.0027	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000168	0.00265	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000165	0.00259	CbGpPWpGaD
Etravirine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000164	0.00257	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000163	0.00257	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000154	0.00242	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—MAOA—alcohol dependence	0.000154	0.00242	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	0.000149	0.00235	CbGpPWpGaD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000146	0.00229	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP2E1—alcohol dependence	0.000144	0.00227	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000142	0.00224	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000134	0.00211	CbGpPWpGaD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000133	0.00208	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GGT1—alcohol dependence	0.000132	0.00208	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000132	0.00207	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.00013	0.00204	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000128	0.00201	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000121	0.0019	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—MAOA—alcohol dependence	0.000119	0.00187	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000109	0.00171	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000108	0.0017	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000108	0.0017	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.000108	0.00169	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000104	0.00164	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—POMC—alcohol dependence	0.0001	0.00158	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	8.85e-05	0.00139	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	8.75e-05	0.00137	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	8.68e-05	0.00136	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	8.56e-05	0.00134	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ADH6—alcohol dependence	8.34e-05	0.00131	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ADH6—alcohol dependence	8.14e-05	0.00128	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GGT1—alcohol dependence	7.97e-05	0.00125	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—POMC—alcohol dependence	7.73e-05	0.00121	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ADH6—alcohol dependence	7.6e-05	0.00119	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—MAOA—alcohol dependence	7.14e-05	0.00112	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—POMC—alcohol dependence	7.05e-05	0.00111	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ADH1A—alcohol dependence	6.91e-05	0.00109	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ADH1A—alcohol dependence	6.75e-05	0.00106	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—EP300—alcohol dependence	6.65e-05	0.00105	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ADH1A—alcohol dependence	6.3e-05	0.00099	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ADH4—alcohol dependence	5.88e-05	0.000923	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ADH4—alcohol dependence	5.74e-05	0.000901	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ADH4—alcohol dependence	5.36e-05	0.000842	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	5.09e-05	0.000799	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADH6—alcohol dependence	5.02e-05	0.000788	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	5.01e-05	0.000787	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ADH7—alcohol dependence	5e-05	0.000785	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ADH7—alcohol dependence	4.88e-05	0.000766	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GGT2—alcohol dependence	4.79e-05	0.000753	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GGT2—alcohol dependence	4.68e-05	0.000735	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—POMC—alcohol dependence	4.65e-05	0.00073	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	4.64e-05	0.000729	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	4.6e-05	0.000723	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ADH7—alcohol dependence	4.56e-05	0.000716	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ADH1B—alcohol dependence	4.38e-05	0.000688	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GGT2—alcohol dependence	4.37e-05	0.000686	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ADH1B—alcohol dependence	4.28e-05	0.000672	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADH1A—alcohol dependence	4.16e-05	0.000653	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	4.14e-05	0.000651	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ADH1B—alcohol dependence	3.99e-05	0.000628	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MAOB—alcohol dependence	3.63e-05	0.00057	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MAOB—alcohol dependence	3.54e-05	0.000557	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADH4—alcohol dependence	3.53e-05	0.000555	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MAOB—alcohol dependence	3.31e-05	0.00052	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALDH2—alcohol dependence	3.09e-05	0.000485	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALDH2—alcohol dependence	3.01e-05	0.000473	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADH7—alcohol dependence	3e-05	0.000472	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.97e-05	0.000466	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GGT2—alcohol dependence	2.88e-05	0.000453	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALDH2—alcohol dependence	2.81e-05	0.000442	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.71e-05	0.000425	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADH1B—alcohol dependence	2.63e-05	0.000414	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GOT2—alcohol dependence	2.62e-05	0.000412	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GOT2—alcohol dependence	2.56e-05	0.000403	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2E1—alcohol dependence	2.47e-05	0.000388	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2E1—alcohol dependence	2.41e-05	0.000378	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GOT2—alcohol dependence	2.39e-05	0.000376	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GGT1—alcohol dependence	2.27e-05	0.000356	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GOT1—alcohol dependence	2.27e-05	0.000356	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2E1—alcohol dependence	2.25e-05	0.000354	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GGT1—alcohol dependence	2.21e-05	0.000347	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GOT1—alcohol dependence	2.21e-05	0.000347	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MAOB—alcohol dependence	2.18e-05	0.000343	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GGT1—alcohol dependence	2.07e-05	0.000325	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GOT1—alcohol dependence	2.07e-05	0.000325	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MAOA—alcohol dependence	2.03e-05	0.000319	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MAOA—alcohol dependence	1.98e-05	0.000311	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.97e-05	0.000309	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.86e-05	0.000292	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MAOA—alcohol dependence	1.85e-05	0.000291	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.8e-05	0.000282	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GOT2—alcohol dependence	1.58e-05	0.000248	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.48e-05	0.000233	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GGT1—alcohol dependence	1.36e-05	0.000214	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GOT1—alcohol dependence	1.36e-05	0.000214	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—POMC—alcohol dependence	1.32e-05	0.000208	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—POMC—alcohol dependence	1.29e-05	0.000203	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MAOA—alcohol dependence	1.22e-05	0.000192	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—POMC—alcohol dependence	1.21e-05	0.000189	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—EP300—alcohol dependence	8.77e-06	0.000138	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—EP300—alcohol dependence	8.56e-06	0.000134	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—EP300—alcohol dependence	8e-06	0.000126	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—POMC—alcohol dependence	7.95e-06	0.000125	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—EP300—alcohol dependence	5.27e-06	8.29e-05	CbGpPWpGaD
